Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medium Biosciences
San Francisco, California, United Statesmedium.bio ↗
- Ownership
- Private
- Employees
- ~8
- Development stage
- Preclinical
01
Overview
Medium Biosciences develops AI models and new assays to create functional, therapeutic proteins. Their software platform enables industrial biotechnology companies to interface with machine learning models for enzyme engineering. The company is focused on accelerating the discovery of high-performing protein sequences that would otherwise require extensive wet lab work. No clinical results are reported as they are primarily a platform provider.
- Modalities
- Protein therapeuticsEnzyme engineering
- Industry
- Drug Discovery Services
02
Partnerships
Y Combinator (investor/accelerator partnership)
Beyond the preview
Go deeper on Medium Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medium Biosciences.